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Background: The two main complications associated with the use of assisted reproduction techniques, ovarian
hyperstimulation syndrome and multiple pregnancies, could be eliminated by milder ovarian stimulation protocols
and the increased use of a single embryo transfer (SET) policy. A retrospective, cohort study was performed in
private infertility centre to evaluate the embryological and clinical results of a large exclusively SET program
according to patient age (lower or equal 29, 30–34, 35–39, 40–44 and equal or higher 45 years).
Materials: A total of 7,244 infertile patients have undergone 20,244 cycles with a clomiphene-based minimal
stimulation or natural cycle IVF protocol during 2008. Following oocyte retrieval, fertilization and embryo culture a
total of 10,401 fresh or frozen single embryo transfer procedures were performed involving cleavage-stage embryos
or blastocysts.
Results: Successful oocyte retrieval rate (78.0 %) showed no age-dependent decrease until 45 years. Fertilization
(80.3 %) and cleavage (91.1 %) rates were not significantly different between age groups. Blastocyst formation
(70.1 % to 22.8 %) and overall live birth rates (35.9 % to 2 %) showed an age-dependent decrease. Frozen-thawed
blastocyst transfer cycles gave the highest chance of live birth per embryo transfer (41.3 % to 6.1 %).
Conclusions: High fertilization and cleavage rates were obtained regardless of age whereas blastocyst formation
and live birth rates showed an age-dependent decrease. An elective single embryo transfer program based on a
minimal ovarian stimulation protocol yields acceptable live birth rates per embryo transfer in infertile patients up
until their mid-forties. However in very advanced age patients (equal or higher 45 years old) success rates fall below 1 %.
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In recent years there has been an increasing interest in
developing new milder approaches in in-vitro fertilization
treatment that might decrease the physical burden and psy-
chological distress for patients, increase patient conveni-
ence and contribute to reducing treatment costs [1]. The
risks of the two main complications associated with the use
of assisted reproduction techniques, ovarian hyperstimula-
tion syndrome and multiple pregnancies, are reduced re-
spectively by milder ovarian stimulation protocols and the* Correspondence: k-kato@towako.net
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reproduction in any medium, provided the orincreased use of an elective single embryo transfer (SET)
policy.
Kato Ladies Clinic (KLC) has pioneered minimal
stimulation protocols since 1994 by developing an in-
novative ovarian stimulation regimen based on clomi-
phene citrate and triggering final oocyte maturation with
a GnRH agonist [2]. More recently, from 2002, an even
milder approach was developed and natural cycle IVF
was increasingly used for ovulatory women in our centre
[3,4]. In this regimen the only pharmaceutical interven-
tion consisted in inducing the final oocyte maturation
with a GnRH agonist. Guidelines of the Japanese Society
for Reproductive Medicine on the number of transferred
embryos (2007) recommended single embryo transfer for. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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transfers. SET has been a routine practice in KLC for more
than a decade however a 100 % single embryo transfer pol-
icy was implemented in our center for blastocyst transfers
from 2006 and for cleavage-stage embryos from 2008.
The purpose of the present study is to report the
results of an exclusively single embryo transfer program
based on mild ovarian stimulation/natural cycle IVF pro-
tocols with over 20,000 started cycles and to analyze out-
come according to patient age.
Methods
Patients
The study period was between January and December 2008
including all cycles performed in KLC. Institutional Review
Board approval was not required for the present study due
to its retrospective nature and to the fact that study data
was constantly managed in a way which excluded the iden-
tification of subjects. Our patient population was composed
of infertile patients of advanced mean age (39.4± 4.7 years)
including many patients with previous failed treatment
cycles performed in others centers. A clomiphene based
minimal stimulation protocol was used in the majority of
our patients whereas from 2002 onwards natural cycle IVF
was increasingly offered to normally cycling women.
Data collection
A dataset was created by summarizing all oocyte retrie-
vals and embryo transfers procedures (including fresh
cleavage, fresh blastocyst, vitrified cleavage and vitrified
blastocyst transfers) performed during the study period
according to five different female age groups (≤29, 30–34,
35–39, 40–44 and ≥45 years). Because it was not possible
to link original oocyte retrievals with their respective
embryo transfer procedures (when elective cryopreserva-
tion occurred with a subsequent frozen-thawed embryo
transfer in the next cycle) or to follow-up patients who
performed successive stimulation cycles, we could not cal-
culate pregnancy rates per started cycle or cumulative suc-
cess rates. However an estimate of “per planned oocyte
retrieval” success rates was done by dividing all live births
(that resulted from different types of embryo transfer pro-
cedures) by the number of planned oocyte retrievals in the
same age group. This would lead to minimal bias because
the only imprecision would result from patients who per-
formed their frozen-thawed embryo transfer outside of the
one-year study period or who moved to a different age
group during the short time interval between oocyte re-
trieval and subsequent frozen embryo transfer.
Minimal stimulation and natural cycle IVF protocol
All patients received detailed information about the pro-
posed treatment option. A written informed consent was
obtained from the participants of the study and theyhave also agreed that their de-identified data could be
used for research purposes. A clomiphene citrate (CC)
based minimal stimulation protocol was used in the ma-
jority of cycles (82 %) whereas unstimulated natural cycle
IVF (16.2 %) or letrozole stimulated cycles (1.8 %) were
used in a smaller proportion of started cycles. Details of
the clomiphene-based minimal stimulation protocol were
described previously [2]. Briefly CC (50 to 100 mg/day)
was administrated orally with an extended regimen from
cycle day 3 until the day before inducing final oocyte
maturation. Human menopausal gonadotropin (hMG) or
recombinant FSH was added in the form of injections
(50 to 150 IU/every other day) or nasal spray in 77.4 %
of CC-based stimulation protocols in order to obtain 1
to 4 mature follicles. Monitoring involving ultrasound
scan and hormonal profile (E2, LH and progesterone)
was usually started on day 8 and continued every other
day until triggering day. Ovulation triggering was performed
with a GnRH agonist, busereline (Suprecur, 600 μg), admin-
istered in a nasal spray form.
In the natural cycle IVF protocol the only pharmaceut-
ical intervention consisted of inducing the final oocyte
maturation with a GnRH agonist. Monitoring consisted
of an ultrasound scan and hormonal profile (E2, LH and
progesterone) and was usually started in the morning of
day 10 and/or 12 according to the patient’s cycle length.
When the leading follicle reached 18 mm with a con-
comitant E2 level ≥ 250 pg/ml oocyte retrieval was sched-
uled. Oocyte retrieval was usually performed 30–34
hours after triggering although in some cases where the
start of the LH surge was detected it was anticipated to
20–30 hours after triggering [4].
Oocyte retrieval, conventional insemination and ICSI
procedure
The absence of follicles on ultrasound before starting the
oocyte retrieval was assumed to be due to premature
ovulation. Oocyte retrieval was performed without
anesthesia using an extra-thin 21 G needle (Kitazato,
Japan). Follicular flushing was not used during the re-
trieval. Conventional insemination was performed ap-
proximately 3 hours after retrieval and intracytoplasmic
sperm injection (ICSI) was performed after a 5 hour
interval. The P1/cleavage stage medium supplemented
with 10 % SSS (Irvine Scientific, US) was used as a cul-
ture medium. ICSI was the preferred insemination
method in the presence of moderate/severe male factor
infertility, for oocytes that matured in-vitro after oocyte
retrieval or in case of previous fertilization failure.
Fertilization assessment was done 16–20 hours after
insemination. Normally fertilized zygotes with two pro-
nuclei were cultured individually in a drop of 20 μl of
Quinn’s Advantage Protein Plus cleavage medium
(SAGE, US) from day 1 to 3. Following this, the embryos
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blastocyst medium (SAGE, US) from day 4 to 6. All
embryos were cultured at 37°C under the gas phase of
5 % O2, 5 % CO2 and 90 %N2 with 100 % humidity in
water jacket small multigas incubators (Astec, Japan).
The liquid nitrogen was produced by a N2 generator sys-
tem in a 10,000 class clean room environment.Embryo culture, frozen-thawed cycles and embryo
transfer procedure
During the study period only single embryo transfers
were performed in our center and an exclusive SET pol-
icy was strictly observed. Patients were counseled ac-
cordingly before their treatment started about the risk of
multiple pregnancies, the benefits of an elective single
embryo transfer and the possibility of embryo cryo-
preservation. Approximately, half of the embryo transfers
(47.1 %) were performed at day 2 or 3 with a fresh cleav-
age-stage embryo whereas in most of the remaining
cases (47.4 %) embryos were cultured to blastocyst-stage
and vitrified electively for subsequent use in frozen-
thawed blastocyst transfer cycles. Details of the vitrifica-
tion method using the Cryotop® (Kitazato, Japan) were
described previously [5]. Elective frozen-thawed blasto-
cyst transfer was preferred in the presence of tubal factor
infertility (tubal obstruction, hydrosalpinx or the history
of extrauterine pregnancy) or recurrent implantation fail-
ures with cleavage-stage embryos.
Frozen-thawed embryo transfers were performed in
spontaneous natural or hormonal replacement cycles. In
natural cycles, cleavage-stage embryos and blastocysts
were transferred on day 2 and 5 respectively after ovula-
tion was confirmed. In hormonal replacement cycles,
transdermal estradiol patches were started from cycle
day 2 and dydrogesterone was added from cycle day 11
after which cleavage-stage embryos or blastocysts were
transferred 1 or 7 days later, respectively. All embryo
transfer procedures were performed under vaginal ultra-
sound guidance using a specially designed soft catheter
(Kitazato, Japan) by placing a single embryo in minimal
volume to the mid-uterine cavity [6]. Dydrogesterone
(30 mg/day orally) was routinely administered during the
early luteal phase both after fresh and frozen-thawed
embryo transfer procedures. Moreover intramuscular orTable 1 Results of oocyte retrieval according to age
≤29 30-34 35-3
Planned OR, n 448 2751 6595
Premature ovulations, n(%) 10(2.23) 65(2.36) 160(2.
Successful OR, n(%) 372(83) 2243(81.5) 5378(8
ORs with mature oocyte, n(%) 314(70.1) 1957(71.1) 4787(7
a Cochran-Armitage test for trend.intravaginal progesterone was also added until the 9th
pregnancy week in cases where the endogenous proges-
terone production from the placenta was found to be
insufficient.
Outcome measures and pregnancy definitions
Primary outcome measures were clinical pregnancy and
live birth rates per embryo transfer. Secondary outcome
measures were the rate of successful oocyte retrievals
as well as subsequent fertilization, cleavage rates and
blastocyst formation rates. Biochemical pregnancy was
defined by a serum β-hCG level ≥20.0 mIU/ml approxi-
mately 14 days after embryo transfer. An intrauterine
gestational sac revealed by ultrasound scan approxi-
mately 4 weeks after transfer was considered to be a clin-
ical pregnancy. Miscarriage was defined as a pregnancy
loss occurring after detection of a clinical pregnancy up
to the 21st week of pregnancy. Multiple pregnancies
were defined by the presence of more than one gesta-
tional sac or yolk sac or fetal heart beats. Nominal vari-
ables were analyzed by the Cochran-Armitage test for
trend. P< 0.05 was considered statistically significant.
Results
Altogether a total of 20,244 cycles were scheduled for
oocyte retrieval in 7,244 patients. The mean age of
patients undergoing oocyte retrieval was 39.4 ± 4.7 years
(range: 22–53 years). The average number of retrieved
oocytes per scheduled cycle was 1.54. The rates of pre-
mature ovulation detected at oocyte retrieval, successful
oocyte retrievals and those with mature oocytes accord-
ing to different age groups are summarized in Table 1.
No significant differences were observed in the pro-
portion of successful retrievals according to different
age groups except a significantly lower rate in ≥45 years
old women. Following oocyte retrieval no cases of intra-
peritoneal hemorrhage occurred that needed hospitali-
zation. No cases of moderate/severe OHSS were observed
following the above-mentioned minimal stimulation/natural
cycle IVF protocols which was combined with GnRH
agonist trigggering.
The fertilization, cleavage and blastocyst formation
rates according to different age groups are summarized
in Table 2. No significant differences were observed inAge (years)
9 40-44 ≥45 Total pa
7600 2850 20244 -
43) 172(2.26) 60(2.11) 476(2.35) -0.46
1.5) 5838(76.8) 1951(68.5) 15782(78) <0.0001
2.6) 5171(68) 1698(59.6) 13927(68.8) <0.0001
Table 2 Embryological results according to age
Age (years)
≤29 30-34 35-39 40-44 ≥45 Total pa
Fertilization rate
IVF, % 76.6 73.6 76.1 79.9 77.7 77 0.07
ICSI, % 85.4 83.7 83.1 83.1 83 83.2 0.75
Cleavage rate
IVF, % 92.4 89.2 87.5 88.5 87.7 88.3 0.7
ICSI, % 93.9 95 94.7 92.7 90.2 93.4 0.24
Blastocyst formation rate
IVF, % 70.5 67 64.4 49.7 25.9 57.3 <0.0001
ICSI, % 69.8 59.5 56 40.1 21.7 46.6 <0.0001
a Cochran-Armitage test for trend.
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groups within the conventional IVF and ICSI groups.
However both fertilization (p = 0.001) and cleavage rates
(p = 0.003) were slightly higher in the ICSI group com-
pared to conventional IVF. In contrast with the previous
two variables the blastocyst formation rate was higher
(p< 0.0001) in the conventional IVF group. The blastocyst
formation rate showed a statistically highly significant age-
dependent decline (p< 0.0001).
Out of a total 10,401 performed embryo transfer pro-
cedures, 4,902 (47.1 %) were fresh cleavage-stage embryo
transfers, 149 (1.4 %) fresh blastocyst transfers, 416 (4 %)
frozen-thawed cleavage-stage embryo transfers and 4,934
(47.4 %) frozen-thawed blastocyst transfers. The mean age
of patients undergoing embryo transfer was 38.1 ± 4.1 years
(range: 22–50 years). Average survival rates after thawing
were 98 % for vitrified cleavage-stage embryos and 95 %,
and for vitrified blastocysts. Clinical pregnancy and live
birth rates per embryo transfer according to five age
groups are summarized in Table 3. An age-dependentTable 3 Pregnancy and live birth rates per embryo transfer ac
≤29 30-34 35-3
Fresh embryo transfer, n 159 931 197
Clinical pregnancies, n(%) 53(33.3) 324(34.8) 507(2
Live births, n(%) 48(30.2) 275(29.5) 376(1
Fresh blastocyst transfer, n 17 29 25
Clinical pregnancies, n(%) 6(35.3) 15(51.7) 9(36
Live births, n(%) 6(35.3) 11(37.9) 7(28
Vitrified embryo transfer, n 13 64 125
Clinical pregnancies, n(%) 5(38.5) 33(51.6) 38(30
Live births, n(%) 4(30.8) 24(37.5) 30(2
Vitrified blastocyst transfer, n 184 1024 207
Clinical pregnancies, n(%) 93(50.5) 553(54) 998(4
Live births, n(%) 76(41.3) 456(44.5) 757(3
a Cochran-Armitage test for trend.decrease in live birth rates was observed after 35 years in
all embryo transfer groups which was statistically highly
significant in all except the fresh blastocyst group with the
smallest sample size. The oldest patient achieving a live
birth in this series was 48 years old. Compared to other
groups the frozen-thawed blastocyst transfer resulted in
the highest live birth rates in all age groups (Figure 1). An
estimation of total live birth rates per planned oocyte re-
trieval showed that success rates decreased gradually from
30 to 0.46 % in ≤29 years up to≥ 45 years old patients, re-
spectively (Table 4.)
Overall multiple pregnancy rates were 0.9 % consisting
of monozygotic twins, which is almost comparable to the
overall twinning rate of Japanese population. Extrauter-
ine pregnancy rates were significantly lower after single
blastocyst transfer 0.36 % (9/2,523) compared to cleavage-
stage embryos 1.41 % (19/1,351), p< 0.0001.Discussion
The present retrospective cohort study demonstrates that
an elective single embryo transfer program based on the
use of minimal stimulation/natural cycle IVF protocols
yields good embryological results (fertilization, cleavage,
blastocyst formation rates) and leads to acceptable live
birth rates in infertile patients of advanced age up until
their mid-forties.
Successful oocyte retrieval rates - with the obtention of
at least one mature oocyte - were not affected until 45 years
of age and then drop by only approximately 10 %. As the
majority of cycles were clomiphene-based this might be
related to the fact that premature LH surges were effi-
ciently blocked by the extended CC regimen [7]. In com-
parison in a recent series the rate of successful oocyte
retrievals was lower in nIVF cycles compared to the
observed retrieval rate in our study (66 % versus 78 %) [4].cording to age
Age (years)
9 40-44 ≥45 Total pa
2 1428 412 4902 -
5.7) 179(12.5) 4(1) 1067(21.8) <0.0001
9.1) 106(7.4) 2(0.5) 807(16.5) <0.0001
73 5 149 -
) 20(27.4) 2(40) 52(34.9) 0.29
) 10(13.7) 1(20) 35(23.5) 0.036
153 61 416 -
.4) 18(11.8) 2(3.3) 95(22.8) <0.0001
4) 12(7.8) 0(0) 70(16.8) <0.0001
2 1489 165 4934 -
8.2) 471(31.6) 33(20) 2149(43.6) <0.0001
6.5) 263(17.7) 10(6.1) 1562(31.7) <0.0001
Figure 1 Age-specific live birth rates per embryo transfer in different embryo transfer groups (with 95 % CI).
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high cancellation rates due to premature LH surges and
the loss of a single follicle following premature ovulation
detected at the retrieval.
Fertilization and cleavage rates were high regardless of
patient age. Overall fertilization rates were slightly (5-6 %)
higher with ICSI which was described previously [8].
Therefore in the context of minimal ovarian stimulation
protocols where only a single or a few mature oocytes are
available the routine use of ICSI might be beneficial. Con-
versely blastocyst formation rates were significantly lower
after ICSI which might be related to a higher proportion
of male factor infertility among couples requiring ICSI [9].
Both blastocyst formation and subsequent live birth rates
showed a highly significant age dependent decrease which
is related to an inevitable decline in oocyte quality. None-
theless the good overall embryological results might be
related to the beneficial effect of milder stimulation proto-
cols. It was previously demonstrated that the proportion
of euploid embryos are significantly higher following
milder compared to conventional high-dose ovarian
stimulation [10]. Furthermore mild approaches might also
improve endometrial receptivity and luteal function which
are altered following conventional ovarian stimulation. It
is interesting to note that in our series, higher clinical
pregnancy and live birth rates were obtained in frozen-Table 4 Estimated total live birth rates per planned oocyte re
≤29 30-34 35-3
Planned OR, n 448 2751 6595
Total embryo transfers n, (%) 373(83.3) 2048(74.4) 4194(6
Total live births n,(%) 134(30) 766(27.8) 1170(1
a Cochran-Armitage test for trend.thawed embryo cycles compared to fresh cycles both with
cleavage-stage embryos and blastocysts (Figure 1). This
might be related to the potential anti-oestrogenic effect of
CC on the endometrial level in fresh cycles which, in con-
trast, is abolished in natural cycle/hormonal replacement
frozen-thawed embryo transfer cycles.
Not surprisingly and in line with previous studies
[11,12] an age-related decline in success rates was also
demonstrated in our series but in the setting of minimal
ovarian stimulation. This is an important issue because
our patient population is particularly biased for advanced
aged women. In fact more than half (52 %) of the cycles
involved ≥40 year-old infertile patients and a non-negli-
gible proportion (14 %) represented very advanced age
(≥45 years-old) women. A rough estimation of the over-
all efficiency of minimal ovarian stimulation is possible
by comparing age-specific live birth rates per embryo
transfer from our series with large US registry cohorts
such as the Society for Assisted Reproductive Technol-
ogy (SART, www.sart.org) data from 2008. Although suc-
cess rates of our fresh cleavage-stage SET group are
generally lower than SART data, the frozen-thawed SBT
group yields very close or in some older age groups
probably even higher results than overall results of the
US cohort (with transfer of 2.2-3.3 embryos). A less
biased comparison made with another European SETtrieval according to age
Age (years)
9 40-44 ≥45 Total pa
7600 2850 20244 -
3.6) 3143(41.4) 643(22.6) 10401(51.4) <0.0001
7.7) 391(5.1) 13(0.46) 2474(12.2) <0.0001
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ventional ovarian stimulation was used - suggests that
after one transfer cycle live birth rates per embryo transfer
are comparable (27.9 % versus 26 %) with the two
approaches. The very advanced age (≤45 years) patient
group represents a particular challenge especially in Japan
where oocyte donation treatment is not practiced. In our
series for this age group live birth rates per started cycle
have fallen below 1 % which is qualified as a “futile treat-
ment” by recent ASRM guidelines [14]. Nonetheless those
few patients who are still able to perform a frozen-thawed
blastocyst embryo transfer could achieve a somewhat
more encouraging 6 % success rate. In fact most (10/13)
live births in very advanced age patients in our series were
obtained with this approach. In contrast it seems that less
complex milder approaches such as natural cycle IVF
might reach their limit in very advanced aged women.
A peculiarity of both protocols (clomiphene based and
natural cycle) used in this series is that the induction of
final oocyte maturation was performed with a GnRH
agonist instead of hCG. To our knowledge no other
group has used this approach routinely in minimal
stimulation or natural cycle IVF protocols. In other clin-
ical situations such as high-responder IVF patients or
oocyte donors GnRH agonist triggering was shown to
practically eliminate any risk of moderate/severe OHSS
[15]. It was also suggested that avoiding hCG might have
additional beneficial effects on the maturation rate of
obtained oocytes [16] or luteal function [2].
An important advantage of an exclusively single embryo
transfer program is the dramatic reduction in multiple ges-
tation rates. In the previously mentioned 2008 SART co-
hort involving non-donor IVF cycles multiple gestation
rates varied, according to age, between 15.4-33.3 % for
twins and 0.6-1.9 % for triplets and occurred at all groups
without exception. In the setting of a single embryo trans-
fer program only monozygotic twinning (MZT) occurs. In
our series MZT rate was low (0.9 %) compared to other
reports and might be associated to blastocyst culture [17].
In our series a reduced rate of extrauterine pregnancy
was observed following blastocyst transfer in comparison
with cleavage-stage embryos. It was suggested that a higher
embryonic implantation potential and a lower number of
transferred embryos are factors that diminish the risk of an
ectopic pregnancy after assisted reproductive techniques
[18].
Limitations of the present study are related to potential
heterogeneity in patient characteristics, stimulation pro-
tocols used or the presence of four different embryo
transfer strategies which is inevitable when evaluating
such a large number of cycles. Exact live birth rates are
presented “per embryo transfer” whereas only an estima-
tion could be performed to show “per cycle” success
rates which take into account the proportion of cancelledcycles that finally did not reach embryo transfer. More-
over cumulative live were not presented in this study be-
cause it was not possible to link successive patient cycles
performed over a relatively short one-year study period.
On the other hand this large one year cohort from a single-
centre gives a useful insight into the overall efficiency of
minimal stimulation protocols combined with a strict SET
policy.Conclusions
The present study shows that an elective single embryo
transfer program based on minimal stimulation ovarian
protocols can yield acceptable live birth rates per embryo
transfer in infertile patients up until their mid-forties. In
very advanced age patients (≥45 years old) however per
cycle success rates fall below 1 %. The combination of
mild stimulation protocols, a highly efficient embryo
cryopreservation technique and a single embryo transfer
policy could provide the base for establishing a new con-
cept of innovative, patient-friendly and low-risk in-vitro-
fertilization treatment. Further prospectively designed
studies stretching over several years are needed to evalu-
ate age-specific cumulative live birth rates after a series
of successive treatment cycles using minimal ovarian
stimulation.
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